Pharmaceutical Manufacturing of Ophthalmic Solution

The contract involves the manufacturing of sterile, prescription-grade tetracaine hydrochloride ophthalmic solution, specifically packaged in 5 mL bottles. The production must comply with FDA current Good Manufacturing Practices (cGMP) to ensure quality and safety standards appropriate for pharmaceutical products. Additionally, the packaging requirements must meet military standards, reflecting the contract's alignment with Department of Defense specifications. This subcontract, issued by the Medical Supply Chain Pharmacy FSA under the Department of Defense, targets production at Fort Bragg, with a solicitation posted in May 2026 and a response deadline in late May 2026. The work falls under the NAICS code 325412, which pertains to pharmaceutical manufacturing. This contract aims to support military medical needs by ensuring the availability of high-quality ophthalmic solutions manufactured under strict regulatory and military guidelines.